Rita Abi-Raad, MD
Associate Professor of PathologyDownloadHi-Res Photo
Cards
Appointments
Pathology
Primary
Additional Titles
Associate Residency Program Director, Pathology
Contact Info
Appointments
Pathology
Primary
Additional Titles
Associate Residency Program Director, Pathology
Contact Info
Appointments
Pathology
Primary
Additional Titles
Associate Residency Program Director, Pathology
Contact Info
About
Titles
Associate Professor of Pathology
Associate Residency Program Director, Pathology
Biography
Dr. Abi-Raad received her MD from Saint Joseph University- School of Medicine in Lebanon in 1994. She completed her residency in Anatomic and Clinical pathology and a fellowship in cytopathology at Yale New Haven Hospital. Dr. Abi-Raad is board certified in Clinical and Anatomic Pathology, and Cytopathology.
Appointments
Pathology
Associate Professor on TermPrimary
Other Departments & Organizations
Education & Training
- Fellow
- Yale-New Haven Hospital (2016)
- Resident
- Yale-New Haven Hospital (2015)
- MD
- UNIVERSITE SAINT JOSEPH - LEBANON (1994)
Research
Overview
Medical Subject Headings (MeSH)
Head and Neck Neoplasms; Thyroid Cancer, Papillary
Research at a Glance
Yale Co-Authors
Frequent collaborators of Rita Abi-Raad's published research.
Publications Timeline
A big-picture view of Rita Abi-Raad's research output by year.
Pei Hui, PhD, MD
Natalia Buza, MD
Andrea Barbieri, MD
Catherine Dinauer, MD
Guoping Cai, MD, MS
Matthew Grant, MD, FIDSA
8Publications
118Citations
Publications
2021
Expression of NKX3.1, Prostatic Specific Antigen and Prostatic Specific Alkaline Phosphatase in Cytology Specimens of Metastatic Prostatic Carcinoma.
Wang M, Abi-Raad R, Adeniran AJ, Cai G. Expression of NKX3.1, Prostatic Specific Antigen and Prostatic Specific Alkaline Phosphatase in Cytology Specimens of Metastatic Prostatic Carcinoma. Journal Of Clinical And Translational Pathology 2021, 1: 16-20. PMID: 35265947, PMCID: PMC8903190, DOI: 10.14218/jctp.2021.00015.Peer-Reviewed Original ResearchCitations
2020
Gomori Methenamine Silver Stain on Bronchoalveolar Lavage Fluid Is Poorly Sensitive for Diagnosis of Pneumocystis jiroveci Pneumonia in HIV-Negative Immunocompromised Patients and May Lead to Missed or Delayed Diagnoses
Azar MM, Slotkin R, Abi-Raad R, Liu Y, Grant MH, Malinis MF. Gomori Methenamine Silver Stain on Bronchoalveolar Lavage Fluid Is Poorly Sensitive for Diagnosis of Pneumocystis jiroveci Pneumonia in HIV-Negative Immunocompromised Patients and May Lead to Missed or Delayed Diagnoses. Archives Of Pathology & Laboratory Medicine 2020, 144: 1003-1010. PMID: 31904277, DOI: 10.5858/arpa.2019-0394-oa.Peer-Reviewed Original ResearchCitationsAltmetricConceptsHIV-negative immunocompromised patientsBronchoalveolar lavage fluidDiagnosis of PJPHIV-positive patientsImmunocompromised patientsLavage fluidGomori methenamine silver stainingPneumocystis jiroveci pneumoniaHIV-positive casesHuman immunodeficiency virusGomori methenamine silver stainMethenamine silver stainingMethenamine silver stainJiroveci pneumoniaBAL fluidHistorical gold standardRetrospective reviewImmunodeficiency virusPatientsLow burdenDiagnosisGMS stainGold standardPJPPneumonia
2019
Grading Pancreatic Neuroendocrine Tumors by Ki-67 Index Evaluated on Fine-Needle Aspiration Cell Block Material
Abi-Raad R, Lavik JP, Barbieri AL, Zhang X, Adeniran AJ, Cai G. Grading Pancreatic Neuroendocrine Tumors by Ki-67 Index Evaluated on Fine-Needle Aspiration Cell Block Material. American Journal Of Clinical Pathology 2019, 153: 74-81. PMID: 31415691, DOI: 10.1093/ajcp/aqz110.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and Concepts
2018
The Value of Negative Diagnosis in Thyroid Fine-Needle Aspiration: a Retrospective Study with Histologic Follow-Up
Abi-Raad R, Prasad M, Baldassari R, Schofield K, Callender GG, Chhieng D, Adeniran AJ. The Value of Negative Diagnosis in Thyroid Fine-Needle Aspiration: a Retrospective Study with Histologic Follow-Up. Endocrine Pathology 2018, 29: 269-275. PMID: 29949024, DOI: 10.1007/s12022-018-9536-5.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsFine-needle aspirationThyroid fine-needle aspirationFalse negative rateBenign diagnosisFNA diagnosisIncidence of malignancySubsequent surgical resectionCategory of patientsPapillary-like nuclear featuresNoninvasive follicular thyroid neoplasmLarge academic centerPapillary thyroid carcinomaThyroid FNA resultsFalse-negative casesFollicular thyroid neoplasmSurgical resectionRetrospective reviewBenign goiterInadequate biopsiesLymphocytic thyroiditisNeoplastic casesRetrospective studyTumor sizeNIFTP casesSurgical follow
2015
C-Cell Neoplasia in Asymptomatic Carriers of RET Mutation in Extracellular Cysteine-Rich and Intracellular Tyrosine Kinase Domain
Abi-Raad R, Virk RK, Dinauer CA, Prasad A, Morotti RA, Breuer CK, Sosa JA, Udelsman R, Rivkees SA, Prasad ML. C-Cell Neoplasia in Asymptomatic Carriers of RET Mutation in Extracellular Cysteine-Rich and Intracellular Tyrosine Kinase Domain. Human Pathology 2015, 46: 1121-1128. PMID: 26033033, DOI: 10.1016/j.humpath.2015.04.011.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsAdolescentAdultCarcinoma, NeuroendocrineChildChild, PreschoolFemaleGenetic Predisposition to DiseaseGerm-Line MutationHeterozygoteHumansInfantMaleMiddle AgedMultiple Endocrine NeoplasiaProtein Structure, TertiaryProto-Oncogene MasProto-Oncogene Proteins c-retThyroid NeoplasmsYoung AdultConceptsMedullary thyroid carcinomaMultiple endocrine neoplasia type 2C-cell hyperplasiaAsymptomatic carriersC-cell neoplasiaRET mutationsMTC familiesHigh-risk RET mutationsIntracellular tyrosine kinase domainTyrosine kinase domainC-cell diseaseC-cell pathologyLymph node metastasisCodon 918 mutationYounger median ageReceptor tyrosine kinase proteinTotal thyroidectomyProgressive diseaseMedian ageNode metastasisThyroid carcinomaType 2Germline mutationsTyrosine kinase proteinFormer groupDiagnostic application of KRAS mutation testing in uterine microglandular proliferations
Hong W, Abi-Raad R, Alomari AK, Hui P, Buza N. Diagnostic application of KRAS mutation testing in uterine microglandular proliferations. Human Pathology 2015, 46: 1000-1005. PMID: 25997988, DOI: 10.1016/j.humpath.2015.03.010.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsMeSH KeywordsAdenocarcinomaAdultAgedAged, 80 and overBiopsyCell ProliferationCervix UteriDiagnosis, DifferentialDNA Mutational AnalysisEndometrial HyperplasiaEndometrial NeoplasmsFemaleHumansMiddle AgedMutationPredictive Value of TestsProto-Oncogene ProteinsProto-Oncogene Proteins p21(ras)Ras ProteinsConceptsKRAS mutation analysisEndometrial adenocarcinomaMicroglandular hyperplasiaMicroglandular patternKRAS mutationsCareful morphological assessmentEndometrial mucinous carcinomaKRAS mutation testingCases of EMAMutation analysisFrequent KRAS mutationsElectronic medical recordsDifferential diagnostic toolHigh mitotic activityEndometrial biopsyImmunohistochemical workupUterine cervixMucinous carcinomaClinical historyDiagnostic challengeDiagnostic dilemmaGlandular proliferationMucinous lesionsMedical recordsEAC cases
2014
Mitotically Active Microglandular Hyperplasia of the Cervix
Abi-Raad R, Alomari A, Hui P, Buza N. Mitotically Active Microglandular Hyperplasia of the Cervix. International Journal Of Gynecological Pathology 2014, 33: 524-530. PMID: 25083971, DOI: 10.1097/pgp.0000000000000086.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsHuman papillomavirus (HPV) statusMicroglandular hyperplasiaSmall biopsy specimensEndometrial malignancyClinical historyBiopsy specimensHigh risk human papillomavirus statusCarcinoembryonic antigenKi-67 proliferation indexMitotic activityModerate nuclear atypiaPatient's clinical historySignet ring cellsSignificant mitotic activityReticular growth patternMicroglandular patternVimentin immunostainsPatient ageCase seriesEndocervical polypEndometrial adenocarcinomaEndocervical glandsDiagnostic dilemmaClinical prognosisMucinous differentiation
2013
Frequent KRAS mutation in complex mucinous epithelial lesions of the endometrium
Alomari A, Abi-Raad R, Buza N, Hui P. Frequent KRAS mutation in complex mucinous epithelial lesions of the endometrium. Modern Pathology 2013, 27: 675-680. PMID: 24186144, DOI: 10.1038/modpathol.2013.186.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsPositive predictive valueMucinous lesionsKRAS mutationsMucinous changeMucinous adenocarcinomaEndometrial mucinous carcinomaHigh positive predictive valueComplex atypical hyperplasiaRisk stratification algorithmAtypical complex hyperplasiaImportant prognostic indicatorFrequent KRAS mutationsKRAS mutation analysisComplex hyperplasiaHysterectomy specimensClinical progressionEndometrial lesionsMucinous carcinomaAtypical hyperplasiaPrognostic indicatorMucinous differentiationEpithelial lesionsCurettage casesStratification algorithmPredictive value
Academic Achievements and Community Involvement
activity Papanicolaou Society of Cytopathology
CommitteesMemberDetails2018 - Present
Clinical Care
Overview
Clinical Specialties
Pathology; Anatomic Pathology; Cytopathology
Board Certifications
Cytopathology
- Certification Organization
- AB of Pathology
- Original Certification Date
- 2016
Anatomic & Clinical Pathology
- Certification Organization
- AB of Pathology
- Original Certification Date
- 2015
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileLinks & Media
News
- June 27, 2023
Yale Pathology Joins Office of Health Equity Research in Community Listening Session
- February 23, 2023
Yale Pathology to Have Large Representation at USCAP Annual Meeting
- August 01, 2022
Andrea Barbieri, MD, Takes Over as Director of Pathology Residency Training Program
- May 11, 2022
Andrea Barbieri, MD, to Succeed Diane Kowalski, MD, MMSc, as Director of Pathology Residency Training Program